<DOC>
	<DOCNO>NCT00740259</DOCNO>
	<brief_summary>Flunarizine calcium channel blocker traditionally use treatment vertigo migraine . It also mechanism action associate antipsychotic activity ( D2 receptor blockade ) , never test . The investigator hypothesis flunarizine atypical antipsychotic .</brief_summary>
	<brief_title>Efficacy Tolerability Flunarizine Treatment Schizophrenia : Comparison With Haloperidol</brief_title>
	<detailed_description>The main advantage flunarizine D2 receptor blocker long half-life , may administer weekly may delay relapse medication interrupt .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Flunarizine</mesh_term>
	<criteria>DSMIV schizophrenic schizoaffective patient 18 55 year old PANSS score 45 . Clinical disease Pregnancy Drug dependence ( except nicotine ) past month history refractory least 2 antipsychotic take appropriately .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>flunarizine</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>antipsychotic</keyword>
</DOC>